Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wong

Showing results (31-40 of 401) with videos related to

Pageof 41
Sort By:
Experimental Neurology|October 22, 2011
Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformationsMichael Wong
Epilepsy Currents|February 28, 2012
A Tuber-ful Animal Model of Tuberous Sclerosis At Last?Michael Wong
Biomedical Journal|May 7, 2013
Mammalian target of rapamycin (mTOR) pathways in neurological diseasesMichael Wong
Epilepsy Currents|February 15, 2014
mTOR Strikes Again: mTORC1 Activation Causes Epilepsy Independent of Overt Pathological ChangesMichael Wong
Epilepsia Open|April 4, 2022
Commentary on "The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia"Michael Wong
Journal of Child Neurology|October 7, 2009
Correspondence on ''effect of acupuncture on the brain in children with spastic cerebral palsy using functional neuroimaging (fMRI)''Michael Wong, Yiu Ming
Expert Review of Neurotherapeutics|February 9, 2016
Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsyAnna Jeong, Michael Wong
Australian Journal of General Practice|November 14, 2024
An approach to the postoperative parotidectomy patient in primary careMichael Wong, Sarju Vasani
Epilepsia|January 17, 2012
Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in ratBo Zhang, Michael Wong
Epilepsia|July 16, 2016
Systemic disease manifestations associated with epilepsy in tuberous sclerosis complexAnna Jeong, Michael Wong
Pageof 41

Showing results (31-40 of 401) with videos related to

Sort By:
Pageof 41
Experimental Neurology|October 22, 2011
Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformationsMichael Wong
Epilepsy Currents|February 28, 2012
A Tuber-ful Animal Model of Tuberous Sclerosis At Last?Michael Wong
Biomedical Journal|May 7, 2013
Mammalian target of rapamycin (mTOR) pathways in neurological diseasesMichael Wong
Epilepsy Currents|February 15, 2014
mTOR Strikes Again: mTORC1 Activation Causes Epilepsy Independent of Overt Pathological ChangesMichael Wong
Epilepsia Open|April 4, 2022
Commentary on "The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia"Michael Wong
Journal of Child Neurology|October 7, 2009
Correspondence on ''effect of acupuncture on the brain in children with spastic cerebral palsy using functional neuroimaging (fMRI)''Michael Wong, Yiu Ming
Expert Review of Neurotherapeutics|February 9, 2016
Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsyAnna Jeong, Michael Wong
Australian Journal of General Practice|November 14, 2024
An approach to the postoperative parotidectomy patient in primary careMichael Wong, Sarju Vasani
Epilepsia|January 17, 2012
Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in ratBo Zhang, Michael Wong
Epilepsia|July 16, 2016
Systemic disease manifestations associated with epilepsy in tuberous sclerosis complexAnna Jeong, Michael Wong
Pageof 41